Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025 and Provide Business Update on Thursday, May 29, 2025

(NASDAQ:ROIV),(NasdaqGM:ROIVW), BASEL, Switzerland and LONDON and NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) — Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 29, 2025, to report its financial results for the fourth quarter and fiscal year ended March 31, 2025, and […]

Range Impact Reports 1Q 2025 Financial Results

Range Impact Reports 1Q 2025 Financial Results GlobeNewswire May 15, 2025 Cleveland, Ohio, May 15, 2025 (GLOBE NEWSWIRE) — Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in Appalachia, reports its results for the first quarter ended March 31, 2025.

High Roller Reports Q1 2025 Results

High Roller Reports Q1 2025 Results GlobeNewswire May 15, 2025 â— Q1 2025 revenue increased 4% YoY to $6,770,886 â— Commenced reorganization and strategic shift to regulated market operating profile â— Successfully submitted initial licensing application to access Ontario's regulated online gambling market Las Vegas, Nevada, May 15, 2025 (GLOBE NEWSWIRE) — High Roller Technologies

Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025 and Provide Business Update on Thursday, May 29, 2025

Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025 and Provide Business Update on Thursday, May 29, 2025 GlobeNewswire May 15, 2025 BASEL, Switzerland and LONDON and NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) — Roivant (Nasdaq: ROIV) today announced that it will host a live conference call

Solid Biosciences Reports First Quarter 2025 Financial Results and Provides Business Updates

(NASDAQ:SLDB), – Duchenne (SGT-003): Participant dosing ongoing in the Phase 1/2 INSPIRE DUCHENNE trial; Solid on track to discuss accelerated pathways with U.S. FDA later in 2025 – – FA (SGT-212): Dosing of first participant anticipated in the second half of 2025 – – CPVT (SGT-501): FDA IND on track for submission first half of

ARRAY Unveils Hail XP: An Industry-Leading Tracker for Extreme Weather Protection

(NasdaqGM:ARRY), ALBUQUERQUE, N.M., May 15, 2025 (GLOBE NEWSWIRE) — ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading global provider of solar tracking technology products, software and services, today unveiled DuraTrack Hail XP(TM), the Company's most advanced tracker designed to withstand extreme hail and wind events. Hail XP builds on ARRAY's proven DuraTrack(R) platform

Solid Biosciences Reports First Quarter 2025 Financial Results and Provides Business Updates

Solid Biosciences Reports First Quarter 2025 Financial Results and Provides Business Updates GlobeNewswire May 15, 2025 – Duchenne (SGT-003): Participant dosing ongoing in the Phase 1/2 INSPIRE DUCHENNE trial; Solid on track to discuss accelerated pathways with U.S. FDA later in 2025 – – FA (SGT-212): Dosing of first participant anticipated in the second half

ARRAY Unveils Hail XP: An Industry-Leading Tracker for Extreme Weather Protection

ARRAY Unveils Hail XP: An Industry-Leading Tracker for Extreme Weather Protection With 77-degree stow, AC-powered control, and integration with ARRAY's Hail Alert Response system, Hail XP sets a new standard in tracker resilience GlobeNewswire May 15, 2025 ALBUQUERQUE, N.M., May 15, 2025 (GLOBE NEWSWIRE) — ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading

Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement

(NYSE MKT:SENS), GERMANTOWN, Md., May 15, 2025 (GLOBE NEWSWIRE) — Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it has commenced an underwritten public offering, subject to market and other conditions, to

Park Aerospace Corp. Reports Fourth Quarter and Fiscal Year Results

(NYSE:PKE), NEWTON, Kan., May 15, 2025 (GLOBE NEWSWIRE) — Park Aerospace Corp. (NYSE-PKE) reported results for the 2025 fiscal year fourth quarter and full fiscal year ended March 2, 2025. The Company will conduct a conference call to discuss its financial results and other matters at 5:00 p.m. EDT today. A live audio webcast of

Scroll to Top